OTCMKTS:HYPMY Hypermarcas (HYPMY) Stock Price, News & Analysis $4.89 +0.13 (+2.73%) As of 10/2/2026 03:44 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsSEC FilingsShort Interest About Hypermarcas Stock (OTCMKTS:HYPMY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Hypermarcas alerts:Sign Up Key Stats Today's Range$4.70▼$4.8950-Day Range$3.99▼$4.8952-Week Range$3.71▼$5.50Volume2,519 shsAverage Volume8,434 shsMarket Capitalization$3.44 billionP/E Ratio9.78Dividend Yield2.66%Price TargetN/AConsensus RatingBuy Company Overview Hypermarcas S.A. was a Brazilian consumer healthcare company that developed, manufactured and marketed pharmaceutical and healthcare products. Its portfolio included over-the-counter medicines, prescription products, vitamins and other consumer health brands sold through pharmacies and retail channels. The company was historically associated with well-known Brazilian brands such as Benegrip, Biotônico Fontoura, Doril, Engov and Epocler. Hypermarcas also previously operated in personal care, beauty, household cleaning and other consumer categories, but divested many of those businesses as it concentrated on pharmaceuticals and healthcare. In 2018, Hypermarcas changed its corporate name to Hypera S.A., adopting the Hypera Pharma identity. The company’s principal market has been Brazil, with its operations focused on serving the Brazilian healthcare and pharmaceutical market.AI Generated. May Contain Errors. Read More Receive HYPMY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hypermarcas and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HYPMY Stock News HeadlinesHypera ON ADR (HYPMY)September 27, 2026 | es.investing.comHypera S.A. (HYPMY) Q2 2026 Earnings Call TranscriptAugust 11, 2026 | seekingalpha.comFirst Look: Elon’s “Starphone”Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.October 4 at 1:00 AM | Stansberry Research (Ad)Hypera SA ADR (HYPMY)May 24, 2026 | investing.comHypera S.A. (HYPMY) Q3 2025 Earnings Call TranscriptOctober 29, 2025 | seekingalpha.comBrazil's Hypera announces new majority stakeholder groupJuly 7, 2025 | reuters.comHypera S.A. (HYPMY) Stock Price, Quote, News & Analysis - Seeking AlphaJune 29, 2025 | seekingalpha.comHypera S.A. credit rating downgraded due to increased leverageApril 9, 2025 | investing.comSee More Headlines HYPMY Stock Analysis - Frequently Asked Questions How have HYPMY shares performed this year? Hypermarcas' stock was trading at $4.1375 at the start of the year. Since then, HYPMY stock has increased by 18.2% and is now trading at $4.89. How were Hypermarcas' earnings last quarter? Hypermarcas (OTCMKTS:HYPMY) released its quarterly earnings data on Thursday, August, 6th. The company reported $0.14 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.13 by $0.01. Hypermarcas had a trailing twelve-month return on equity of 12.68% and a net margin of 19.77%. How do I buy shares of Hypermarcas? Shares of HYPMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/06/2026Today10/04/2026Next Earnings (Estimated)11/11/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:HYPMY CIK1486749 Webhyperapharma.com.br Phone55-11-3627-4206FaxN/AEmployees10,481Year Founded2001Profitability EPS (Trailing Twelve Months)$0.50 Trailing P/E Ratio9.78 Forward P/E Ratio9.59 P/E GrowthN/ANet Income$213.10 million Net Margins19.77% Pretax MarginN/A Return on Equity12.68% Return on Assets6.78% Debt Debt-to-Equity Ratio0.50 Current Ratio1.86 Quick Ratio1.26 Sales & Book Value Annual Sales$1.38 billion Price / Sales2.50 Cash Flow$0.47 per share Price / Cash Flow10.35 Book Value$3.54 per share Price / Book1.38Miscellaneous Outstanding Shares704,010,000Free FloatN/AMarket Cap$3.44 billion OptionableNot Optionable Beta0.65 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (OTCMKTS:HYPMY) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredNew Chip takes minutes, not daysGeorge Gilder believes today's AI data centers could become tomorrow's typewriters - replaced by a single wafe...Eagle Publishing | SponsoredWATCH THIS BEFORE DECEMBER 8th!!James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has...Paradigm Press | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hypermarcas Please log in to your account or sign up in order to add this asset to your watchlist. Share Hypermarcas With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
